Searcharxiv⌕ Search

arXiv subjects

Hasan Jamil

Publications and source records attributed to Hasan Jamil.

2 recordsLinked to original sources

Stage-Resolved EBV-Induced B-Cell Programs Across CNS Selection and Multiple Sclerosis Compartments

Epstein-Barr virus (EBV) is implicated in multiple sclerosis (MS), but whether EBV-conditioned B cells retain stable transcriptional programs after CNS selection remains uncertain. We reanalyzed datasets spanning experimental EBV infection, CNS-homing B cells in humanized mice, early-MS blood, and paired human CSF and blood. A frozen EBV-induced B-cell factor (F12) was transferred without outcome-driven modification and evaluated using anatomical, sequencing-depth, metabolic, coherence-matched, lineage, and exposure controls. F12 did not predict MS activity (AUC=0.487; p=0.489) and was lower in CSF in nine evaluable participants (mean difference -0.0560; coherence-matched p=0.015). It also remained lower in brain than spleen in all five EBV-exposed mice after matched-depth rarefaction (p=0.0313) and coherence-matched calibration (p=0.0225). The splenic TBX21+CXCR3+ transcriptional gate did not reliably represent the state of anatomically selected brain B cells. An enriched 287-gene cross-system bridge lacked B-lineage and EBV-exposure specificity. In human CSF, an early EBV-associated program was depleted (-0.0492; p=0.0197), whereas latency-III and lymphoblastoid cell line-like programs increased (+0.0666; p=0.0092 and +0.0148; p=0.0096, respectively). Opposite early and late program directions persisted after removing shared genes. No external program met the prespecified prospective criterion. These findings support stage- and compartment-dependent remodeling of EBV-associated B-cell transcription rather than persistence of a stable RNA signature. They distinguish cellular trafficking from transcriptional-state preservation and show that cross-system molecular resemblance alone cannot establish ancestry. EBV-directed biomarker studies should integrate host transcription with virologic, clonotypic, antigen-specific, epigenetic, and longitudinal evidence.

q-bio.GN↗

Genome-Guided Interpretable Screening of Phase-Stable, Lead-Free Double Perovskite Absorbers for All-Inorganic Semiconductors, Sensors, and Photovoltaics with DFT-Validated Design Rules

The discovery of stable, lead-free halide perovskites for optoelectronic applications is constrained by vast compositional space and limited interpretability of conventional screening approaches. We present a genome-guided, physics-informed framework that decodes thermodynamic stability and optoelectronic behavior through four physically interpretable descriptor families: packing, bonding, polarization, and electronic identity. Trained on 1,221 DFT-calculated A2BB'X6 compounds, machine-learning surrogates achieve robust predictive performance, with a recall-optimized stability classifier (ROC-AUC = 0.92) and an XGBoost regressor for band-gap prediction (R2 = 0.93 on held-out data). Applying a staged inverse-design constraint stack to 13,088 charge-balanced, lead-free compositions reduces the search space to five DFT-validated, phase-stable semiconductors: Rb2SnMnBr6, Cs2CdSnBr6, Cs2CdSnI6, Cs2KGaI6, and Cs2AgAlBr6. These candidates lie on the convex hull (E_hull <= 0 meV/atom), preserve ordered double-perovskite structures, and exhibit strong optical absorption (alpha peak ~1e5 cm^-1). Genotype-phenotype coupling analysis reveals a hierarchical control mechanism: packing genes define structural formability, bonding genes govern near-edge optical transitions and conductivity, and optoelectronic response genes regulate dielectric response and exciton screening (epsilon0 = 4.6-8.2). This work establishes a generalizable paradigm for interpretable inverse design, linking descriptor-level genomics to experimentally relevant optoelectronic phenotypes and providing design rules for discovering stable, lead-free double perovskites for photovoltaics, sensing, and transparent electronic applications.

cond-mat.mtrl-sci↗